Belgium· BE-AMP-SAM061311-00
Solu-Cortef S.A.B. Act-O-Vial 100 mg
A hydrocortisone product containing hydrocortisone sodium succinate, registered in Belgium by Pfizer. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Hydrocortisone is registered in 14 of 19 countries.
Countries holding a registration under ATC H02AB09 (hydrocortisone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Hydrocortisone · ATC H02AB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydrocortisone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $1.17 in Czechia to $31.20 in Switzerland — a ×27 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydrocortisone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$31.20
- CZ Czechia$1.17
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Hydrocortisone Sodium Succinate
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- H02AB09
- ATC class
- Hydrocortisone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
1 priced- be_apb3926557EUR 8.2
- be_apb0130302
- be_apb0717280
- be_apb7726888
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
845 interactions on record for hydrocortisone.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrocortisone · interactions on record
845 records
- 63 severe
- 407 moderate
- 40 minor
- 315 info
Most severe, free to view
- DesirudinB01AE01severe
- AmiodaroneC01BD01severe
- DofetilideC01BD04severe
- DronedaroneC01BD07severe
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydrocortisone in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaHYDROCORTISON VUABVUAB Pharma a.s., Roztoky
- FinlandSolu-CortefParanova Oy
- United StatesHydrocortisone sodium succinateZydus Pharmaceuticals USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Germany · Hydrocortison Panpharma
- Estonia · Hydrocortisone Medochemie
- Spain · Hidrocortisona Lorien, Hidrocortisona Normon
- Finland · Hydrocortisone Panpharma
- United Kingdom (Northern Ireland) · Hydrocortisone, Hydrocortisone Medsurge Healthcare Uk
- Croatia · Hidrokortizon Medochemie
- Ireland · Solu-Cortef
- Italy · Flebocortid
- Luxembourg · Solu-Cortef S.A.B. Act-O-Vial
- Latvia · Hydrocortisone Medochemie
- Malta · Hydrocortisone Panpharma
- Netherlands · Hydrocortison Medochemie
- Poland · Corhydron, Hydrocortisone Panpharma
- Portugal · Hidrocortisona, Hidrocortisona Color
- Romania · Hidrocortizon Zentiva, Hydrocortisone Succinat Sodic Eipico
- Slovenia · Solu-Cortef
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd334756-fbc4-40ea-9616-93103c5c25e9 GET /v1/drugs/fd334756-fbc4-40ea-9616-93103c5c25e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Solu-Cortef S.A.B. Act-O-Vial 100 mg",
"name_fr": "Solu-Cortef S.A.B. Act-O-Vial 100 mg",
"name_nl": "Solu-Cortef S.A.B. Act-O-Vial 100 mg",
"amp_code": "SAM061311-00",
"strengths": [
"66.8350",
"66.8350",
"50.0000",
"50.0000",
"18.0000",
"8.8000",
"0.9000"
],
"pack_count": 2,
"substances": [
"Hydrocortisone Sodium Succinate",
"Hydrocortisone",
"Benzyl Alcohol",
"Disodium Hydrogen Phosphate",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Hydrocortisone",
"authorisation_numbers": [
"BE061311"
]
}See everything about hydrocortisone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.